The AACC/Clinical Laboratory Expo is the leading event for clinical chemistry, clinical laboratory science and laboratory medicine products and services.
20.000 participants are expected and BioPorto Diagnostic will be promoting The NGAL Test™, which is CE IVD registered for diagnostic use in Europe and available for research use only in the United States.
What is NGAL?
NGAL is a novel biomarker for diagnosing acute kidney injury (AKI). NGAL provides a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI).
For more information about NGAL please visitwww.ngal.com
BioPorto Diagnostics will be represented at the AACC/Clinical Laboratory Expo with an exhibition stand. Meet Jakob Ohm Eriksen, Product Manager firstname.lastname@example.org, Elaine Lundberg, Product Manager email@example.com and Trine Østerbye, Sales and Marketing Manager firstname.lastname@example.org at booth nr. 2809.
For further information on the event please visit: http://www.aacc.org/events/2011am/expo/pages/default.aspx